Periodic Reporting for period 1 - HyperTargIPS-NK (Hyper-targeting CAR NK cells from induced pluripotent stem cells for novel off-the-shelf anti-tumor therapies)

The HyperTargIPS-NK project aims to combine new technologies from three research laboratories and a stem cell company to develop a revolutionary therapy for patients with devastating recurrent malignancies.The therapy we are developing is based on allogeneic induced...